PL3452075T3 - Oftalmiczna kompozycja farmaceutyczna - Google Patents
Oftalmiczna kompozycja farmaceutycznaInfo
- Publication number
- PL3452075T3 PL3452075T3 PL17907584T PL17907584T PL3452075T3 PL 3452075 T3 PL3452075 T3 PL 3452075T3 PL 17907584 T PL17907584 T PL 17907584T PL 17907584 T PL17907584 T PL 17907584T PL 3452075 T3 PL3452075 T3 PL 3452075T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical composition
- ophthalmic pharmaceutical
- ophthalmic
- composition
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20170053782 | 2017-04-26 | ||
| KR1020170120262A KR101861163B1 (ko) | 2017-04-26 | 2017-09-19 | 안과용 약학 조성물 |
| EP17907584.1A EP3452075B1 (en) | 2017-04-26 | 2017-10-13 | Ophthalmic pharmaceutical composition |
| PCT/KR2017/011293 WO2018199408A1 (en) | 2017-04-26 | 2017-10-13 | Ophthalmic pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3452075T3 true PL3452075T3 (pl) | 2022-02-21 |
Family
ID=62299585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17907584T PL3452075T3 (pl) | 2017-04-26 | 2017-10-13 | Oftalmiczna kompozycja farmaceutyczna |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10646546B2 (pl) |
| EP (1) | EP3452075B1 (pl) |
| JP (1) | JP6677827B2 (pl) |
| KR (1) | KR101861163B1 (pl) |
| CN (1) | CN109475597B (pl) |
| ES (1) | ES2902325T3 (pl) |
| PL (1) | PL3452075T3 (pl) |
| TW (1) | TWI763802B (pl) |
| WO (1) | WO2018199408A1 (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3753548A1 (en) | 2006-06-16 | 2020-12-23 | Regeneron Pharmaceuticals, Inc. | Vegf antagonist formulations suitable for intravitreal administration |
| EP3541365A1 (en) * | 2016-11-21 | 2019-09-25 | Just Biotherapeutics, Inc. | Aflibercept formulations and uses thereof |
| MX2020005170A (es) * | 2017-11-17 | 2020-10-16 | Amgen Inc | Formulaciones de proteinas de fusion vegfr-fc. |
| SG11202010684YA (en) | 2018-05-10 | 2020-11-27 | Regeneron Pharma | High concentration vegf receptor fusion protein containing formulations |
| WO2020055123A1 (ko) * | 2018-09-10 | 2020-03-19 | 삼성바이오에피스 주식회사 | 단백질을 포함하는 액상 조성물 |
| KR102286892B1 (ko) * | 2019-07-08 | 2021-08-06 | 삼천당제약주식회사 | 안과용 단백질 제제의 정제방법 |
| EP3931303A1 (en) | 2019-12-06 | 2022-01-05 | Regeneron Pharmaceuticals, Inc. | Anti-vegf protein compositions and methods for producing the same |
| WO2021125852A1 (ko) * | 2019-12-17 | 2021-06-24 | 주식회사 프로젠 | 신규 주사제 제형 |
| CN116056688A (zh) * | 2020-07-24 | 2023-05-02 | 盼展生物技术有限公司 | 眼用液体组合物 |
| KR102720956B1 (ko) | 2020-12-15 | 2024-10-24 | 삼천당제약주식회사 | 안과용 제형을 포함하는 시린지 |
| TW202245823A (zh) * | 2021-01-14 | 2022-12-01 | 南韓商韓兀生物製藥股份有限公司 | 無穩定劑或實質上無穩定劑之含有天凡諾賽普特（ｔａｎｆａｎｅｒｃｅｐｔ）的穩定眼用組成物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3753548A1 (en) | 2006-06-16 | 2020-12-23 | Regeneron Pharmaceuticals, Inc. | Vegf antagonist formulations suitable for intravitreal administration |
| ES2457442T3 (es) | 2009-05-08 | 2014-04-25 | Pari Pharma Gmbh | Formulaciones farmacéuticas concentradas estabilizadoras de los mastocitos |
| AR091237A1 (es) | 2012-06-01 | 2015-01-21 | Ophthotech Corp | Composiciones que comprenden un aptamero anti factor de crecimiento derivado de plaquetas (anti-pdgf) y un antagonista de factor de crecimiento de endotelio vascular (vegf) |
| US20130323242A1 (en) | 2012-06-01 | 2013-12-05 | Ophthotech Corp. | Compositions comprising an anti-pdgf aptamer and a vegf antagonist |
| CN114288254A (zh) | 2013-09-27 | 2022-04-08 | 韩美药品株式会社 | 长效人生长激素缀合物的制剂 |
| AR102494A1 (es) * | 2014-11-07 | 2017-03-01 | Novartis Ag | Métodos para tratar enfermedades oculares |
| KR101808234B1 (ko) * | 2015-06-23 | 2017-12-12 | (주)알테오젠 | IgG Fc 도메인을 가지는 융합 단백질의 안정한 액상 제제 |
| CN105496955A (zh) * | 2015-12-11 | 2016-04-20 | 北京蓝丹医药科技有限公司 | 一种二氟泼尼酯眼用乳剂及其制备方法 |
| EP3541365A1 (en) * | 2016-11-21 | 2019-09-25 | Just Biotherapeutics, Inc. | Aflibercept formulations and uses thereof |
| WO2019055902A1 (en) * | 2017-09-18 | 2019-03-21 | Amgen Inc. | FUSION PROTEIN FORMULATIONS VEGFR-FC |
-
2017
- 2017-09-19 KR KR1020170120262A patent/KR101861163B1/ko active Active
- 2017-10-13 EP EP17907584.1A patent/EP3452075B1/en active Active
- 2017-10-13 US US16/305,987 patent/US10646546B2/en active Active
- 2017-10-13 WO PCT/KR2017/011293 patent/WO2018199408A1/en not_active Ceased
- 2017-10-13 PL PL17907584T patent/PL3452075T3/pl unknown
- 2017-10-13 ES ES17907584T patent/ES2902325T3/es active Active
- 2017-10-13 JP JP2018563112A patent/JP6677827B2/ja active Active
- 2017-10-13 CN CN201780033996.8A patent/CN109475597B/zh active Active
-
2018
- 2018-03-21 TW TW107109677A patent/TWI763802B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| US10646546B2 (en) | 2020-05-12 |
| CN109475597A (zh) | 2019-03-15 |
| TW201838646A (zh) | 2018-11-01 |
| CN109475597B (zh) | 2022-03-22 |
| TWI763802B (zh) | 2022-05-11 |
| ES2902325T3 (es) | 2022-03-28 |
| JP6677827B2 (ja) | 2020-04-08 |
| KR101861163B1 (ko) | 2018-05-25 |
| WO2018199408A1 (en) | 2018-11-01 |
| US20190160145A1 (en) | 2019-05-30 |
| EP3452075A1 (en) | 2019-03-13 |
| JP2019517513A (ja) | 2019-06-24 |
| EP3452075A4 (en) | 2019-12-11 |
| EP3452075B1 (en) | 2021-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2568579B (en) | Ophthalmic drug compositions | |
| GB201913962D0 (en) | Ophthalmic drug compositions | |
| IL269061A (en) | A pharmaceutical preparation containing Selexifag | |
| IL271986A (en) | pharmaceutical preparation | |
| PL3452075T3 (pl) | Oftalmiczna kompozycja farmaceutyczna | |
| GB201619525D0 (en) | Ophthalmic composition | |
| HUE054930T2 (hu) | Gyógyszerészeti tramadol készítmény szemészeti alkalmazásra | |
| GB201712159D0 (en) | Pharmaceutical composition | |
| PL3583943T3 (pl) | Kompozycja farmaceutyczna | |
| PT3445331T (pt) | Composições oftálmicas farmacêuticas isentas de conservante | |
| IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
| IL272419A (en) | Pharmaceutical composition | |
| GB201719447D0 (en) | Pharmaceutical composition | |
| PL3313370T3 (pl) | Okulistyczna kompozycja farmaceutyczna | |
| PL3646867T3 (pl) | Kompozycja farmaceutyczna | |
| GB201615914D0 (en) | Pharmaceutical composition | |
| IL271513A (en) | Innovative pharmaceutical composition | |
| PL3446682T3 (pl) | Kompozycja okulistyczna | |
| GB201615910D0 (en) | Pharmaceutical composition | |
| PL3424500T3 (pl) | Kompozycja farmaceutyczna zawierająca famitynib | |
| GB201620519D0 (en) | Pharmaceutical composition | |
| GB201616088D0 (en) | Pharmaceutical composition | |
| GB201708329D0 (en) | Pharmaceutical composition | |
| GB201708328D0 (en) | Pharmaceutical composition | |
| GB201705661D0 (en) | Pharmaceutical composition |